DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Peters J, Luddington R, Brown K, Baglin C, Baglin T.
Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?.
Br J Haematol 1997;
99 (02) 467-468
Access:
We do not assume any responsibility for the contents of the web pages of other providers.